HerAnswer.com

 

Click for the BBB Business Review of this Health & Wellness in Roseville CA

Free Standard Shipping
 on all U.S. Orders
90 Day Guarantee

 

About Us   Contact Us   Order Status   Shopping Cart   Privacy   Guarantee

Search Our Site       

HOME
GO SHOPPING!
GIFT IDEAS
SPECIALS
PRODUCT INDEX
SHIPPING INFO
INTERNATIONAL ORDERS
MAIL ORDER FORM
  
Women's Health

Womens Anti-Aging 

NPC Cream

EST Cream

Vaginal Moisturizers 
KegelMaster Exerciser 

Women's Supplements 

Other Womens Products 

Intimacy Answers
  
Skin Care & Beauty

Age-Defying Skin Care 

Mini Facelift 
Neck & Chest Cream 
OHT Peptide 3 Products
Eye Creams 
Lip Enhancers 

Sun Protection 

Vitamin K Cream 

Anti-Cellulite 

TanTowel Sunless Tanner 

Hair Removal 

Hair Loss & Hair Growth
Acne Products
Specialty Skin Care 
NewCurves Breast Enhancer 
Weight Loss
  
Men's Products
  
General Health

General Nutrition 

Urinary Tract Infections
Kidney Stones
Gallstones - GallCleanse
Gout - GoutCleanse
Colds & Flu
Blood Sugar Health
Blood Pressure Health
Liver Health
Digestive Health
Body Odor Blocker
High Cholesterol
Sleep - Relaxation
Detoxification
Pain Relief
Eye Health
Joint Health
Other Health Issues 
  
EZ Plunge
 
Links
Re-Seller Information
 

 

 

R-ALA References

Also try
Vitamin D3 Crème
Tonalin CLA 1285

B-Complex Cream
Can-C Eye Drops

R-ALA Home | R-ALA vs S-ALAIngredients & Directions | References

100% Pure R-ALA (150 mg per capsule) with FREE US Shipping

References
  • Haramaki N, Stewart DB, Aggarwal S, Ikeda H, Reznick AZ, Packer L. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic Biol Med. 1998 Aug;25(3):329-39.
     
  • Chaudiere J, Ferrari-Iliou R. Intracellular antioxidants: from chemical to biochemical mechanisms. Food Chem Toxicol. 1999 Sep-Oct;37(9-10):949-62.
     
  • Packer L, Weber SU, Rimbach G. Molecular aspects of alpha-tocotrienol antioxidant action and cell signalling. J Nutr. 2001 Feb;131(2):369S-73S.


Free US Shipping!
90 capsules
 $42.95   Buy it
  • Packer L, Tritschler HJ. Antioxidant properties and clinical applications of alpha-lipoic acid and dihidrolipoic acid. In Cadenas E, Packer L. Handbook of Antioxidants. New York: Marcel Dekker, 1996: 545-91.
     
  • Jacob S, Ruus P, Hermann R, Tritschler HJ, Maerker E, Renn W, Augustin HJ, Dietze GJ, Rett K. Oral administration of rac-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial. Free Radic Biol Med. 1999 Aug;27(3-4):309-14.
     
  • Ziegler D, Reljanovic M, Mehnert H, Gries FA. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials. Exp Clin Endocrinol Diabetes. 1999;107(7):421-30.
     
  • Morcos M, Borcea V, Isermann B, Gehrke S, Ehret T, Henkels M, Schiekofer S, Hofmann M, Amiral J, Tritschler H, Ziegler R, Wahl P, Nawroth PP. Effect of alpha-lipoic acid on the progression of endothelial cell damage and albuminuria in patients with diabetes mellitus: an exploratory study. Diabetes Res Clin Pract. 2001 Jun;52(3):175-83.
     
  • Valenzuela A, Morgado N. Trans fatty acid isomers in human health and in the food industry. Biol Res. 1999;32(4):273-87.
     
  • Hu FB, Stampfer MJ, Manson JE, Rimm E, Colditz GA, Rosner BA, Hennekens CH, Willett WC. Dietary fat intake and the risk of coronary heart disease in women. N Engl J Med. 1997 Nov 20;337(21):1491-9.
     
  • Salmeron J, Hu FB, Manson JE, Stampfer MJ, Colditz GA, Rimm EB, Willett WC. Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr. 2001 Jun;73(6):1019-26.
     
  • Zimmer G, Mainka L, Ulrich H. ATP synthesis and ATPase activities in heart mitoplasts under influence of R(+)- and S(-)-enantiomers of lipoic acid. Methods Enzymol. 1995;251:332-40.
     
  • Rao G. Insulin resistance syndrome. Am Fam Physician. 2001 Mar 15;63(6):1159-63, 1165-6.
     
  • Kwiterovich PO Jr. The metabolic pathways of high-density lipoprotein, low-density lipoprotein, and triglycerides: a current review. Am J Cardiol. 2000 Dec 21;86(12A):5L-10L.
     
  • Egan BM, Greene EL, Goodfriend TL. Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep. 2001 Apr;3(2):107-16.
     
  • Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab. 1998 Aug;83(8):2773-6.
     
  • Jouven X, Charles MA, Desnos M, Ducimetiere P. Circulating nonesterified fatty acid level as a predictive risk factor for sudden death in the population. Circulation. 2001 Aug 14;104(7):756-61.
     
  • Konrad T, Vicini P, Kusterer K, Hoflich A, Assadkhani A, Bohles HJ, Sewell A, Tritschler HJ, Cobelli C, Usadel KH. alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes. Diabetes Care. 1999 Feb;22(2):280-7.
     
  • Jacob S, Henriksen EJ, Schiemann AL, Simon I, Clancy DE, Tritschler HJ, Jung WI, Augustin HJ, Dietze GJ. Enhancement of glucose disposal in patients with type 2 diabetes by alpha-lipoicacid. Arzneimittelforschung. 1995 Aug;45(8):872-4.
     
  • Estrada DE, Ewart HS, Tsakiridis T, Volchuk A, Ramlal T, Tritschler H, Klip A. Stimulation of glucose uptake by the natural coenzyme alpha-lipoic acid/thioctic acid: participation of elements of the insulin signaling pathway. Diabetes. 1996 Dec;45(12):1798-804.
     
  • Yaworsky K, Somwar R, Ramlal T, Tritschler HJ, Klip A. Engagement of the insulin-sensitive pathway in the stimulation of glucose transport by alpha-lipoic acid in 3T3-L1 adipocytes. Diabetologia. 2000 Mar;43(3):294-303.
     
  • Streeper RS, Henriksen EJ, Jacob S, Hokama JY, Fogt DL, Tritschler HJ. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle. Am J Physiol. 1997 Jul;273(1 Pt 1):E185-91.
     
  • Konrad D, Somwar R, Sweeney G, Yaworsky K, Hayashi M, Ramlal T, Klip A. The antihyperglycemic drug alpha-lipoic acid stimulates glucose uptake via both GLUT4 translocation and GLUT4 activation: potential role of p38 mitogen-activated protein kinase in GLUT4 activation. Diabetes. 2001 Jun;50(6):1464-71.
     
  • Loeblein K, Rett K, Maerker E, Tritschler HJ, Wessel K, Wicklmayr M, Haring HU. Thioctic acid stimulates translocation of glucose transports in hearts of insulin-resistant Zucker rats. Diabetologia. 1995 Aug; 38(1):A132(Abs512).
     
  • Hermann R, Niebch G. Human pharmacokinetics of ?-lipoic acid. In Fuchs J, Packer L, Zimmer G (eds), Lipoic Acid in Health and Disease. 1997; New York: Marcel Dekker Inc, 337-60.
     
  • Podda M, Tritschler HJ, Ulrich H, Packer L. Alpha-lipoic acid supplementation prevents symptoms of vitamin E deficiency. Biochem Biophys Res Commun. 1994 Oct 14;204(1):98-104.
     
  • Breithaupt-Grogler K, Niebch G, Schneider E, Erb K, Hermann R, Blume HH, Schug BS, Belz GG. Dose-proportionality of oral thioctic acid--coincidence of assessments via pooled plasma and individual data. Eur J Pharm Sci. 1999 Apr;8(1):57-65.
     
  • Hermann R, Niebch G. "Human pharmacokinetics of a-lipoic acid." In Fuchs J, Packer L, Zimmer G (eds), Lipoic Acid in Health and Disease. 1997; New York: Marcel Dekker Inc, 337-60.
     
  • Gleiter CH, Schug BS, Hermann R, Elze M, Blume HH, Gundert-Remy U. Influence of food intake on the bioavailability of thioctic acid enantiomers. Eur J Clin Pharmacol. 1996;50(6):513-4.
     
  • Maitra I, Serbinova E, Tritschler HJ, Packer L. Stereospecific effects of R(+)-Lipoic Acid on buthionine sulfoximine-induced cataract formation in newborn rats. Biochem Biophys Res Commun. 1996 Apr 16;221(2):422-9.
     
  • Biewenga GP, Haenen GR, Bast A. The pharmacology of the antioxidant lipoic acid. Gen Pharmacol. 1997 Sep;29(3):315-31.
     
  • Morikawa T, Yasuno R, Wada H. Do mammalian cells synthesize lipoic acid? Identification of a mouse cDNA encoding a lipoic acid synthase located in mitochondria. FEBS Lett. 2001 Jun 1;498(1):16-21.
     
  • Handelman GJ, Han D, Tritschler H, Packer L. Alpha-lipoic acid reduction by mammalian cells to the dithiol form, and release into the culture medium. Biochem Pharmacol. 1994 May 18;47(10):1725-30.
     
  • Kozlov AV, Gille L, Staniek K, Nohl H. Dihydrolipoic acid maintains ubiquinone in the antioxidant active form by two-electron reduction of ubiquinone and one-electron reduction of ubisemiquinone. Arch Biochem Biophys. 1999 Mar 1;363(1):148-54.
     
  • Suzuki YJ, Tsuchiya M, Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic Res Commun. 1993;18(2):115-22.
     
  • Schonheit K, Gille L, Nohl H. Effect of alpha-lipoic acid and dihydrolipoic acid on ischemia/reperfusion injury of the heart and heart mitochondria. Biochim Biophys Acta. 1995 Jun 9;1271(2-3):335-42.
     
  • Biewenga GP, Veening-Griffioen DH, Nicastia AJ, Haenen GR, Bast A. Effects of dihydrolipoic acid on peptide methionine sulfoxide reductase. Arzneimittelforschung. 1998 Feb;48(2):144-8.
     
  • Biewenga GP, Dorstijn MA, Verhagen JV, Haenen GR, Bast A. Reduction of lipoic acid by lipoamide dehydrogenase. Biochem Pharmacol. 1996 Feb 9;51(3):233-8.
     
  • Loffelhardt S, Bonaventura C, Locher M, Borbe HO, Bisswanger H. Interaction of alpha-lipoic acid enantiomers and homologues with the enzyme components of the mammalian pyruvate dehydrogenase complex. Biochem Pharmacol. 1995 Aug 25;50(5):637-46.
     
  • Haramaki N, Han D, Handelman GJ, Tritschler HJ, Packer L. Cytosolic and mitochondrial systems for NADH- and NADPH-dependent reduction of alpha-lipoic acid. Free Radic Biol Med. 1997;22(3):535-42.
     
  • Exner R, Wessner B, Manhart N, Roth E. Therapeutic potential of glutathione. Wien Klin Wochenschr. 2000 Jul 28;112(14):610-6.
     
  • Hagen TM, Vinarsky V, Wehr CM, Ames BN. (R)-alpha-lipoic acid reverses the age-associated increase in susceptibility of hepatocytes to tert-butylhydroperoxide both in vitro and in vivo. Antioxid Redox Signal. 2000 Fall;2(3):473-83.
     
  • Lockhart B, Jones C, Cuisinier C, Villain N, Peyroulan D, Lestage P. Inhibition of L-homocysteic acid and buthionine sulphoximine-mediated neurotoxicity in rat embryonic neuronal cultures with alpha-lipoic acid enantiomers. Brain Res. 2000 Feb 14;855(2):292-7.
     
  • Aguirre N, Barrionuevo M, Ramirez MJ, Del Rio J, Lasheras B. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport. 1999 Nov 26;10(17):3675-80.
     
  • Rybak LP, Husain K, Whitworth C, Somani SM. Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system. Toxicol Sci. 1999 Feb;47(2):195-202.
     
  • Packer L, Tritschler HJ, Wessel K. Neuroprotection by the metabolic antioxidant alpha-lipoic acid. Free Radic Biol Med. 1997;22(1-2):359-78.
     
  • McGahon BM, Martin DS, Horrobin DF, Lynch MA. Age-related changes in LTP and antioxidant defenses are reversed by an alpha-lipoic acid-enriched diet. Neurobiol Aging. 1999 Nov-Dec;20(6):655-64.
     
  • Sayre LM, Perry G, Atwood CS, Smith MA. The role of metals in neurodegenerative diseases. Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):731-41.
     
  • Graham JM, Paley MN, Grunewald RA, Hoggard N, Griffiths PD. Brain iron deposition in Parkinson's disease imaged using the PRIME magnetic resonance sequence. Brain. 2000 Dec;123 Pt 12:2423-31.
     
  • Bartzokis G, Cummings J, Perlman S, Hance DB, Mintz J. Increased basal ganglia iron levels in Huntington disease. Arch Neurol. 1999 May;56(5):569-74.
     
  • Richardson DR, Mouralian C, Ponka P, Becker E. Development of potential iron chelators for the treatment of Friedreich's ataxia: ligands that mobilize mitochondrial iron. Biochim Biophys Acta. 2001 May 31;1536(2-3):133-40.
     
  • Berg D, Weishaupt A, Francis MJ, Miura N, Yang XL, Goodyer ID, Naumann M, Koltzenburg M, Reiners K, Becker G. Changes of copper-transporting proteins and ceruloplasmin in the lentiform nuclei in primary adult-onset dystonia. Ann Neurol. 2000 Jun;47(6):827-30.
     
  • Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: a central role for bound transition metals. J Neurochem. 2000 Jan;74(1):270-9.
     
  • Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron. 2001 Jun;30(3):665-76.
     
  • Ou P, Tritschler HJ, Wolff SP. Thioctic (lipoic) acid: a therapeutic metal-chelating antioxidant? Biochem Pharmacol. 1995 Jun 29;50(1):123-6.
     
  • Muller L, Menzel H. Studies on the efficacy of lipoate and dihydrolipoate in the alteration of cadmium2+ toxicity in isolated hepatocytes. Biochim Biophys Acta. 1990 May 22;1052(3):386-91.
     
  • Suh J, Rocha A, Shigeno E, Frei B, Hagen TM. (R)-alpha-lipoic acid supplementation of old rats decreases age-dependent accumulation of iron and ascorbate depletion in brain. AGE. 1999 Jul; 22(3):121(Abs 19).
     
  • Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. PNAS. 1994 Nov 8;91(23):10771-8.
     
  • Herrero A, Barja G. Effect of aging on mitochondrial and nuclear DNA oxidative damage in the heart and brain throughout the life-span of the rat. J Amer Aging Assoc. 2001 Apr;24(2):45-50.

 
 

Copyright Rose Enterprises,  Phone: (U.S. toll-free) 866-834-0131 (International) 916-772-5214
1079 Sunrise Ave. Ste B-250, Roseville, CA  95661   Site Map


HerAnswer.com on ProvenCredible